Form D · Biotechnology

Prosetta Biosciences Inc.

San Francisco, CA · CIK 0001659956

Offering snapshot reported Dec 4, 2015 · SEC filing

Reported sold
$31.1M
Offering amount: $31.1M
Investors reported
23
Form D · investor count
Minimum accepted
$6.75K
Reported outside-investor minimum
First sale
Feb 6, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 4, 2015Initial$31,096,778No comparison23SEC filing

Offering details

Securities
Equity, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$2.11M
Finders' fees
$0
Form D file number
021-252452
T.R.Winston will also receive warrants to purchase Series D Preferred Stock with an aggregate value equal to 3.0% of gross proceeds raised in the offering and reimbursement for legal expenses up to $50,000.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
T.R. Winston & Company, LLC10571

Source: Form D, filed Dec 4, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Molly Coye Director
Michael D. Farmer Director, Executive
Thomas Higgins Director
David Keys Director
Vishwanath Lingappa Director, Executive
Karl Manheim Director
Joseph("Mike") Mc Cune Director
Phil Satow Director
Cj Sylvester Director
Abel Weinrib Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
670 5th Street
San Francisco, CA, 94107